Skip to main content
SpringerLink
Log in

Alternative and Internet Drugs that Affect Sexual Function

  • Chapter
  • First Online:
Contemporary Treatment of Erectile Dysfunction

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

The purpose of this book chapter is to better understand the role of alternative nonprescription medications and their effect on sexual function. We will also discuss the prevalence of counterfeit prescription medications and their impact on health. We will discuss where these drugs are being produced and how they are regulated by the federal government. The role of the Internet as a method of obtaining these medications also will be explored. The most common alternative medicines will be reviewed based on clinical research trials in terms of efficacy and side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilt T, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA. 1998;280:1604.

    Article  CAS  PubMed  Google Scholar 

  2. Blumenthal M, The American Botanical Council. The ABC, clinical guide to herbs. New York: Thieme; 2003. p. 383–5.

    Google Scholar 

  3. Kaptchuk T. Acupuncture: theory, efficacy and practice. Ann Intern Med. 2002;136:374.

    Article  PubMed  Google Scholar 

  4. Barnes P, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States. Adv Data. 2004;343:1–19.

    PubMed  Google Scholar 

  5. Gutierrez S, Ang-Lee M, Walker D, Zacny J. Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers. Pharmacol Biochem Behav. 2004;78:57–64.

    Article  CAS  PubMed  Google Scholar 

  6. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med. 2001;135:594.

    Article  CAS  PubMed  Google Scholar 

  7. Campbell N, Clark J, Stecher V, Thomas J, Callanan A, Donnelly B, Goldstein I, Kaminetsky J. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 2013;10:1842–9.

    Article  PubMed  Google Scholar 

  8. Newmaster S, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA bar coding detects contamination and substitution in North American herbal products. BMC Med. 2013;11:222.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Stoeckle M, Gamble C, Kirpeka R, Young G, Ahmed S, Little D. Commercial teas highlight plant DNA barcode identification successes and obstacles. Sci Rep. 2011;1:42.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Baker D, Stevenson D, Little D. DNA barcode identification of black cohosh herbal dietary supplements. J AOAC Int. 2012;9:1023–34.

    Article  Google Scholar 

  11. Etienne C. International Medical Products Anti-counterfeiting Taskforce (IMPACT). Counterfeit Drugs Kill! World Health Organization; 2008.

    Google Scholar 

  12. Ko R. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847.

    Article  CAS  PubMed  Google Scholar 

  13. Hill H. Counterfeit medicines—how much of a risk to public health are they? Pharm J. 2005;275:520.

    Google Scholar 

  14. DHHS. Adverse event reporting for dietary supplements: an inadequate safety valve. US: office of the inspector general, HHS; 2001.

    Google Scholar 

  15. Marcus D, Grollman A. Botanical medicines—the need for new regulations. N Engl J Med. 2002;347:2073.

    Article  PubMed  Google Scholar 

  16. Cracking counterfeit: counterfeit medicines—the scope of the problem. Ireland: Pfizer; 2010.

    Google Scholar 

  17. Thompson J, Banks I. European Alliance for Access to Safe Medicines. The counterfeiting superhighway. Eur Alliance Access Safe Med. 2008:1–32.

    Google Scholar 

  18. Ukens C. Pharmacists can help stop counterfeit drugs. Drug Topics. 2004;148:31.

    Google Scholar 

  19. Dorsey P, Hellstrom W. The illicit sale of medications for the treatment of erectile dysfunction. Medscape Urol. 2007:1–8.

    Google Scholar 

  20. US Food and Drug Administration. FDA targets illegal online pharmacies in globally coordinated action. FDA News Release. 2014. Web.

    Google Scholar 

  21. Stecher V, Jackson G, Banks I, Arver S. Analysis of pharmaceuticals seized by authorities for suspicion of being counterfeit viagra (Sildenafil Citrate). Eur Soc Sexual Med. 2009:1.

    Google Scholar 

  22. Venhuis B, Barends D, Zwaagstra M, de Kaste D. Recent developments in counterfeits and imitations of viagra, Cialis and Levitra: a 2005–2006 update. RIVM Rep. 2007:1–55.

    Google Scholar 

  23. Megget K. The “global disaster” of fake internet pharmacies. pharmatechnologist.com. Web. 19 July 2007. Accessed 2 Mar 2015.

    Google Scholar 

  24. Catizone C. Counterfeit drugs and states’ efforts to combat the problem. J Pharm Pract. 2006;19:165–70.

    Article  Google Scholar 

  25. Jackson G, Arver S, Banks I, Strecher V. Counterfeit PDE-5i pose significant safety risk. Int J Clin Pract. 2010;64:497–504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Yun T. Panax ginseng—a non-organ-specific cancer preventive? Lancet Oncol. 2001;2:49–55.

    Article  CAS  PubMed  Google Scholar 

  27. Choi Y, Rha K, Choi H. In vitro and in vivo experimental effect of Korean red ginseng on erection. J Urol. 1999;162:1508–11.

    Article  CAS  PubMed  Google Scholar 

  28. Jang D, Lee M, Byung-Cheul S, Ernst E. Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol. 2008;66:444–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hong B, Ji Y, Hong J, Nam K, Ahn T. A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urology. 2002;168:2070–3.

    Article  CAS  Google Scholar 

  30. Choi H, Choi Y, Kim J. Penile blood change after oral medication of Korean red ginseng in erectile dysfunction patients. J Ginseng Res. 2003;27:165–70.

    Article  Google Scholar 

  31. de Andrade E, de Mesquita A, Claro Jde A, de Andrade P, Ortiz V, Paranhos M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian J Androl. 2007;9:241–4.

    Article  PubMed  Google Scholar 

  32. Kim S, Paick S. Clinical efficacy of Korean red ginseng on vasculogenic impotent patients. Korean J Androl. 1999;17:23–8.

    Google Scholar 

  33. Horny Goats Weed. Herb Wisdom. Hallnet Ltd, n.d. Accessed 1 Mar 2015.

    Google Scholar 

  34. Xu H, Huang Z. Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro. Vascul Pharmacol. 2007;47:18–24.

    Article  CAS  PubMed  Google Scholar 

  35. Ning H, Xin Z, Lin G, Banie L, Lue T, Lin C. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006;68:1350–4.

    Article  PubMed  Google Scholar 

  36. Shindel A, Xin Z, Lin G, Fandel T, Huang Y, Banie L, Breyer B, Garcia M, Lin C, Lue T. Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med. 2010;7:1518–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ye L, Chen J, Liu S. Pharmacokinetics of icariin in rats. Chin Pharmaceut J. 1999;34:33–6.

    CAS  Google Scholar 

  38. Yang W, Yu X, Chen X, Zhang L, Lu C, Zhao Y. Pharmacokinetics and tissue distribution profile of icariin propylene glycol-liposome intraperitoneal injection in mice. J Pharm Pharmacol. 2012;64:190–8.

    Article  CAS  PubMed  Google Scholar 

  39. Partin J, Pushkin Y. Tachyarrhythmia and hypomania with horny goat weed. Psychosomatics. 2004;45:536–7.

    Article  PubMed  Google Scholar 

  40. Goldberg M, Roberston D. Yohimbine; a pharmacological probe for the study of the a2-adrenoreceptor. Pharmacol Rev. 1983;35:143–80.

    CAS  PubMed  Google Scholar 

  41. Porst H, Burnett A, Brock G, Bhanem H, Giuliano F, Glina S, Hellstrom W, Martin-Morales A, Salonia A, Sharlip I. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013;10:130–71.

    Article  CAS  PubMed  Google Scholar 

  42. Simonsen U, Prieto D, Hernandez M, Saenz de Tejada I, Garcia-Sacristan A. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol. 1997;157:2356–60.

    Article  CAS  PubMed  Google Scholar 

  43. Owen J, Nakatsu S, Fenemore J, Condra M, Surridge D, Morales A. The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol. 1987;32:577–82.

    Article  CAS  PubMed  Google Scholar 

  44. Guthrie S, Hariharan M, Grunhaus L. Yohimbine bioavailability in humans. Eur J Clin Pharmacol. 1990;39:409–11.

    Article  CAS  PubMed  Google Scholar 

  45. Montague D, Barada J, Belker A, Levine L, Nadig P, Roehrborn C, Sharlip I, Bennett A. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. J Urol. 1996;156:11.

    Google Scholar 

  46. Adeniyi A, Brindley G, Pryor J, Ralph D. Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl. 2007;9:403–7.

    Article  CAS  PubMed  Google Scholar 

  47. Efsa, ANS Panel (EFSA Panel on Food Additives and Nutrient Sources Added to Food). Scientific Opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum.) Pierre ex Beille). EFSA J. 2013;11:46.

    Google Scholar 

  48. National Center for Complementary and Alternative Medicine. Herbs at a glance: Yohimbe. United States department of health and human services. July 2012. Accessed March 2015.

    Google Scholar 

  49. Gonzales G. Ethnobiology and ethnopharmacology of Lepidium meyenii(Maca), a plant from the peruvian highlands. Evid Based Complement Alternat Med. 2012:1–10.

    Google Scholar 

  50. Clement C, Diazgrados D, Avula B, Kahn I, Mayer A, Aguirre D, Manrique I, Kruezer M. Influence of colour type and previous cultivation on secondary metabolites in hypocotyls and leaves of maca (Lepidium meyenii Walpers). J Sci Food Agric. 2010;90:861–9.

    CAS  PubMed  Google Scholar 

  51. Zheng B. Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats. Urology. 2000;55:598–602.

    Article  CAS  PubMed  Google Scholar 

  52. Brooks N, Wilcox G, Walker K, Ashton J, Cox M, Stojanovska L. Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause. 2008;15:1157–62.

    Article  PubMed  Google Scholar 

  53. Gonzales G, Cordova A, Vega K, Chung A, Villena A, Gonez C, Castillo S. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia. 2002;34:367–72.

    Article  CAS  PubMed  Google Scholar 

  54. Stone M, Ibarra A, Roller M, Zangara A, Stevenson E. A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. J Ethnopharmacol. 2009;126:574–6.

    Article  PubMed  Google Scholar 

  55. Ernst E, Posadzki P, Lee M. Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: an overview of systematic reviews. Maturitas. 2011;70:37–41.

    Article  PubMed  Google Scholar 

  56. Zenico T, Cicero A, Valmorri L, Mercuriali M, Bercovich E. Subjective effects of Lepidium meyenii extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia. 2009;41:95–9.

    Article  CAS  PubMed  Google Scholar 

  57. Piacente S, Carbone V, Plaza A, Zampelli A, Pizza C. Investigation of the tuber constituents of maca (Lepidium meyenii Walp). J Agric Food Chem. 2002;50:5621–5.

    Article  CAS  PubMed  Google Scholar 

  58. APSSA. From the French Agency of Sanitary Security on foods relative to the risk assessment for health by consuming pulverized maca roots or as alimentary supplement. AfssaSaisine 2004-SA-0155 2004:1–3.

    Google Scholar 

  59. Schmitt C, Dirsch V. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide. 2009;21:77–91.

    Article  CAS  PubMed  Google Scholar 

  60. Ude C, Schubert-Zsilavecz M, Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin Pharmacokinet. 2013;52:727–49.

    Article  CAS  PubMed  Google Scholar 

  61. Kang B, Lee S, Kim M, Cho M. A placebo controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol. 2002;17:279–84.

    Article  PubMed  Google Scholar 

  62. Wheatley D. Triple-blind, placebo-controlled trial of Gingko biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol. 2004;19:545–8.

    Article  PubMed  Google Scholar 

  63. National Institutes of Health. Ntp technical report on the toxicology and carcinogenesis studies of Ginkgo biloba (cas no. 90045-36-6) in f344/n rats and b6c3f1/n mice(gavage studies). NIH Publication No. 13-5920. 2013:184.

    Google Scholar 

  64. Hardigree A, Epler J. Comparative mutagenesis of plant flavonoids in microbial systems. Mutat Res. 1978;58:231–9.

    Article  CAS  PubMed  Google Scholar 

  65. Birks J, Grimley E, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002;4. Article ID CD003120.

    Google Scholar 

  66. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355:134–8.

    Article  CAS  PubMed  Google Scholar 

  67. Leistner E, Drewke C. Ginkgo biloba and ginkgotoxin. J Nat Prod. 2010;73:86–92.

    Article  CAS  PubMed  Google Scholar 

  68. Shamloul R. Natural aphrodisiacs. J Sex Med. 2010;7:39–49.

    Article  PubMed  Google Scholar 

  69. Waynberg J. Yohimbine vs. muira puama in the treatment of sexual dysfunction. Am J Nat Med. 1994;1:8–9.

    Google Scholar 

  70. Cavallini G. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging. Urology. 2004;62:641–6.

    Article  Google Scholar 

  71. University of Maryland Medical Center. Carnitine (l-Carnitine). University of Maryland Medical Center (UMMC). March 2011. Accessed March 2015.

    Google Scholar 

  72. Komori K, Tsujimura A, Takao T, Matsuoka Y, Miyagawa Y, Takada S, Honomura N, Okuyama A. Nitric oxide synthesis leads to vascular endothelial growth factor synthesis via the NO/cyclic guanosine 3′,5′-monophosphate (cGMP) pathway in human corpus cavernosal smooth muscle cells. J Sex Med. 2008;5:1623–35.

    Article  CAS  PubMed  Google Scholar 

  73. Morris Jr S. Enzymes of arginine metabolism. J Nutr. 2004;134:2743S–7.

    CAS  PubMed  Google Scholar 

  74. Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Effect of oral administration of high-dose nitric oxide donor l-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int. 1999;83:269–73.

    Article  CAS  Google Scholar 

  75. Klotz T, Mathers M, Braun M, Bloch W, Engelmann U. Effective of oral l-arginine in first line treatment of erectile dysfunction in a controlled crossover study. Urol Int. 1999;62:220–3.

    Article  Google Scholar 

  76. Cormio L. Oral l-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology. 2011;77:119–22.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Ochsner Medical Center, 1514 Jefferson Hwy, Urology Clinic AT-4, New Orleans, LA, 70121, USA

    Jonathan Israel MD & Eric L. Laborde MD

Authors
  1. Jonathan Israel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric L. Laborde MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric L. Laborde MD .

Editor information

Editors and Affiliations

  1. Southern Illinois University School of Medicine, Springfield, Illinois, USA

    Tobias S. Köhler

  2. Division of Urology Department of Surgery, Southern Illinois University School of Medicine Hospital Affiliates, Springfield, Illinois, USA

    Kevin T. McVary

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Israel, J., Laborde, E.L. (2016). Alternative and Internet Drugs that Affect Sexual Function. In: Köhler, T., McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-31587-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31587-4_10

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-31585-0

  • Online ISBN: 978-3-319-31587-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation